EcoDrugPlus

Solute Carrier Family 9 Member A3

Ensembl ID : ENSPLOG00000003168
Gene Symbol: SLC9A3
2 Cross references
234 Possible Orthologues:

Somatostatin Receptor 1

Ensembl ID : ENSPLOG00000002837
Gene Symbol: SSTR1
4 Cross references
158 Possible Orthologues:

Somatostatin Receptor 2

Ensembl ID : ENSPLOG00000006332
Gene Symbol: SSTR2
2 Cross references
263 Possible Orthologues:

Somatostatin Receptor 3

Ensembl ID : ENSPLOG00000003258
Gene Symbol: SSTR3
4 Cross references
249 Possible Orthologues:

Somatostatin Receptor 4

Ensembl ID : ENSPLOG00000000946
Gene Symbol: SSTR4
4 Cross references
100 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSPLOG00000018939
Gene Symbol: SSTR5
4 Cross references
256 Possible Orthologues:

Sphingosine Kinase 2

Ensembl ID : ENSPLOG00000008685
Gene Symbol: SPHK2
4 Cross references
209 Possible Orthologues:

Sphingosine-1-Phosphate Receptor 1

Ensembl ID : ENSPLOG00000013902
Gene Symbol: S1PR1
4 Cross references
200 Possible Orthologues:

Spleen Associated Tyrosine Kinase

Ensembl ID : ENSPLOG00000011610
Gene Symbol: SYK
4 Cross references
200 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSPLOG00000010987
Gene Symbol: SRD5A2
2 Cross references
263 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSPLOG00000018992
Gene Symbol: SOAT1
4 Cross references
210 Possible Orthologues:

Sucrase-Isomaltase

Ensembl ID : ENSPLOG00000016507
Gene Symbol: SI
4 Cross references
200 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).